Abstract

The integration of genetic insights into clinical cardiac electrophysiology is revolutionizing the understanding, diagnosis, and management of cardiac arrhythmias. Advances in genetic research have identified numerous genetic mutations and variations associated with arrhythmias, such as long QT syndrome, Brugada syndrome, and familial atrial fibrillation. This article explores the impact of genetic discoveries on clinical cardiac electrophysiology, emphasizing how genetic insights enhance risk stratification, guide personalized treatment strategies, and contribute to the development of targeted therapies.